公告日期：2026-01-30

ADAMA Provides Financial Performance Estimation for the Full Year of
2025

TEL AVIV, ISRAEL and BEIJING, CHINA, January 29, 2026 – ADAMA Ltd. (the “Company”) (SZSE
000553), today provided an estimate regarding its financial performance for the full year of 2025. The
Company saw further positive impact of its “Fight Forward” strategic transformation plan, with improvements
in key financial metrics, including positive adjusted net profit and significantly reduced reported net loss.

Sales

For the full year of 2025, ADAMA is expecting to report a decline in revenues of approximately 1% to 4% in
USD compared to the full year of 2024. The decline in revenues was generally attributable to lower prices
and the Company’s decisions to optimize its portfolio and geographical presence and to pivot away from
selling some basic chemical products, as well as significant declines in Turkey in Q1. Prices remained weak
mainly due to low prices of active ingredients in light of overcapacity, as well as a high-interest-rate
environment and low commodity prices, which put pressure on distributors and farmers.

Adjusted EBITDA and Net Profit

For the full year of 2025, the Company is expecting to report an increase in adjusted EBITDA and in its
margin, in comparison to the full year of 2024. Adjusted EBITDA and its margin improved due to an increase
in the gross profit and its margin, mainly reflecting the positive impacts of lower costs due to improved
operational efficiency and lower costs of inventory sold, more than compensating for lower prices.

The Company expects to report an adjusted net profit in the range of USD 4 million to 54 million for the full
year of 2025, compared to a loss of USD 206 million for the full year of 2024. The profit was mainly due to a
higher adjusted operating profit and lower tax and financial expenses.

Adjusted net profit (loss) Estimated Full Year 2024

……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。